Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians

키워드

참고문헌 (79)

1. Attili AF, "Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis", Hepatology, 26, pp.809~818 (1997)
2. Portincasa P, "Cholesterol gallstone disease", Lancet, 368, pp.230~239 (2006)
3. Everhart JE, "Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases", Gastroenterology, 136, pp.376~386 (2009)
4. Farthing M, "Survey of digestive health across Europe: final report. Part 1: the burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe", United European Gastroenterol J, 2, pp.539~543 (2014)
5. Diehl AK, "Epidemiology and natural history of gallstone disease", Gastroenterol Clin North Am, 20, pp.1~19 (1991)
6. Sherlock S, "Diseases of the liver and biliary system", pp.597~628 (2002), Blackwell Science
7. Trotman BW, "Pigment vs cholesterol cholelithiasis:comparison of stone and bile composition", Am J Dig Dis, 19, pp.585~590 (1974)
8. Attili AF, "Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)", Am J Epidemiol, 141, pp.158~165 (1995)
9. Shaffer EA, "Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?", Curr Gastroenterol Rep, 7, pp.132~140 (2005)
10. Portincasa P, "Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation?", Hepatology, 55, pp.1313~1316 (2012)
11. Sarin SK, "High familial prevalence of gallstones in the first-degree relatives of gallstone patients", Hepatology, 22, pp.138~141 (1995)
12. Katsika D, "Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs", Hepatology, 41, pp.1138~1143 (2005)
13. Wang DQ, "Biliary lipids and cholesterol gallstone disease", J Lipid Res, 50(Suppl), pp.S406~S411 (2009)
14. Di Ciaula A, "Current views on genetics and epigenetics of cholesterol gallstone disease", Cholesterol, 2013, pp.298421~ (2013)
15. Stender S, "Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study", Hepatology, 58, pp.2133~2141 (2013)
16. Banim PJ, "The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk)", Eur J Gastroenterol Hepatol, 23, pp.733~740 (2011)
17. Di Ciaula A, "Gallbladder and gastric motility in obese newborns, pre-adolescents and adults", J Gastroenterol Hepatol, 27, pp.1298~1305 (2012)
18. Di Ciaula A, "Fat, epigenome and pancreatic diseases: interplay and common pathways from a toxic and obesogenic environment", Eur J Intern Med, 25, pp.865~873 (2014)
19. Leitzmann MF, "The relation of physical activity to risk for symptomatic gallstone disease in men", Ann Intern Med, 128, pp.417~425 (1998)
20. World Health Organization, "Global recommendations on physical activity for health", World Health Organization, ~ (2010)
21. Banim PJ, "Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study", Eur J Gastroenterol Hepatol, 22, pp.983~988 (2010)
22. Chait A, "Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation", J Clin Invest, 64, pp.1309~1319 (1979)
23. Nepokroeff CM, "Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone", Arch Biochem Biophys, 160, pp.387~396 (1974)
24. Subbiah MT, "Cholesterol 7 alpha-hydroxylase of rat liver:an insulin sensitive enzyme", Biochem Biophys Res Commun, 124, pp.896~902 (1984)
25. Kirwan JP, "Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women", J Gerontol, 48, pp.M84~M90 (1993)
26. Seals DR, "Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women", JAMA, 252, pp.645~649 (1984)
27. Tran ZV, "The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies", Med Sci Sports Exerc, 15, pp.393~402 (1983)
28. Mingrone G, "Free fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles", Biochim Biophys Acta, 958, pp.52~59 (1988)
29. Leon AS, "Response of blood lipids to exercise training alone or combined with dietary intervention", Med Sci Sports Exerc, 33(6 Suppl), pp.S502~S515 (2001)
30. Halloran LG, "Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man", Surgery, 84, pp.1~7 (1978)
31. Petitti DB, "Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol", N Engl J Med, 304, pp.1396~1398 (1981)
32. Philipp E, "Cholecystokinin, gastrin and stress hormone responses in marathon runners", Peptides, 13, pp.125~128 (1992)
33. Tsunoda K, "Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake", Hepatogastroenterology, 51, pp.1271~1274 (2004)
34. Tsai CJ, "Fruit and vegetable consumption and risk of cholecystectomy in women", Am J Med, 119, pp.760~767 (2006)
35. Tsai CJ, "The effect of longterm intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study", Ann Intern Med, 141, pp.514~522 (2004)
36. Leitzmann MF, "Coffee intake is associated with lower risk of symptomatic gallstone disease in women", Gastroenterology, 123, pp.1823~1830 (2002)
37. Ruhl CE, "Association of coffee consumption with gallbladder disease", Am J Epidemiol, 152, pp.1034~1038 (2000)
38. Walcher T, "The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence", Eur J Gastroenterol Hepatol, 22, pp.1345~1351 (2010)
39. Kratzer W, "Prevalence of gallstones in sonographic surveys worldwide", J Clin Ultrasound, 27, pp.1~7 (1999)
40. Ginter E, "Chenodeoxycholic acid, gallstones and vitamin C", N Engl J Med, 295, pp.1260~1261 (1976)
41. Simon JA, "Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III)", Arch Intern Med, 160, pp.931~936 (2000)
42. Gustafsson U, "The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time", Eur J Clin Invest, 27, pp.387~391 (1997)
43. Walcher T, "Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population", BMC Gastroenterol, 9, pp.74~ (2009)
44. Portincasa P, "Sonographic evaluation of gallstone burden in humans", Ital J Gastroenterol, 26, pp.141~144 (1994)
45. Barakos JA, "Cholelithiasis: evaluation with CT", Radiology, 162, pp.415~418 (1987)
46. Pereira SP, "Gallstone dissolution with oral bile acid therapy: importance of pretreatment CT scanning and reasons for nonresponse", Dig Dis Sci, 42, pp.1775~1782 (1997)
47. Ledro-Cano D, "Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio-pancreatography?: a systematic review", Eur J Gastroenterol Hepatol, 19, pp.1007~1011 (2007)
48. Mendez-Sanchez N, "Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight", J Nutr, 131, pp.2300~2303 (2001)
49. Portincasa P, "Therapy of gallstone disease: what it was, what it is, what it will be", World J Gastrointest Pharmacol Ther, 3, pp.7~20 (2012)
50. Wang HH, "Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol", Eur J Clin Invest, 43, pp.413~426 (2013)
51. Broomfield PH, "Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight", N Engl J Med, 319, pp.1567~1572 (1988)
52. Weinsier RL, "Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation", Am J Med, 98, pp.115~117 (1995)
53. Johansson K, "Risk of symptomatic gallstones and cholecystectomy after a very-lowcalorie diet or low-calorie diet in a commercial weight loss program:1-year matched cohort study", Int J Obes (Lond), 38, pp.279~284 (2014)
54. Schauer PR, "Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus", Ann Surg, 238, pp.467~484 (2003)
55. Tsai CJ, "Weight cycling and risk of gallstone disease in men", Arch Intern Med, 166, pp.2369~2374 (2006)
56. Li VK, "Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy", Surg Endosc, 23, pp.1640~1644 (2009)
57. Everhart JE, "Contributions of obesity and weight loss to gallstone disease", Ann Intern Med, 119, pp.1029~1035 (1993)
58. Wudel LJ Jr, "Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study", J Surg Res, 102, pp.50~56 (2002)
59. Uy MC, "Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery:a meta-analysis", Obes Surg, 18, pp.1532~1538 (2008)
60. Sugerman HJ, "A multicenter, placebo-controlled, randomized, doubleblind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss", Am J Surg, 169, pp.91~96 (1995)
61. Booker ML, "Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog", Lipids, 25, pp.27~32 (1990)
62. Mizuguchi K, "Preventive effects of eicosapentaenoic acid (EPA) on cholesterol gallstone formation in hamsters", Nihon Yakurigaku Zasshi, 10(Suppl 1), pp.50P~55P (1997)
63. Smit MJ, "Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats", J Clin Invest, 88, pp.943~951 (1991)
64. Tarantino I, "Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure?: a comparative cohort study", Obes Surg, 21, pp.1870~1878 (2011)
65. Worni M, "Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008", Obes Surg, 22, pp.220~229 (2012)
66. Moschetta A, "Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR", Aliment Pharmacol Ther, 15, pp.181~185 (2001)
67. Montini M, "Cholelithiasis and acromegaly: therapeutic strategies", Clin Endocrinol (Oxf), 40, pp.401~406 (1994)
68. Avila NA, "Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course", J Clin Ultrasound, 26, pp.289~294 (1998)
69. Venneman NG, "Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy", Hepatology, 42, pp.1276~1283 (2006)
70. Maringhini A, "Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history", Ann Intern Med, 119, pp.116~120 (1993)
71. Marks JW, "Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man", Dig Dis Sci, 39, pp.1981~1984 (1994)
72. Marjoribanks J, "Long term hormone therapy for perimenopausal and postmenopausal women", Cochrane Database Syst Rev, 7, pp.CD004143~ (2012)
73. Cirillo DJ, "Effect of estrogen therapy on gallbladder disease", JAMA, 293, pp.330~339 (2005)
74. Rubin RA, "Ursodiol for hepatobiliary disorders", Ann Intern Med, 121, pp.207~218 (1994)
75. Villanova N, "Gallstone recurrence after successful oral bile acid treatment: a 12-year follow-up study and evaluation of long-term postdissolution treatment", Gastroenterology, 97, pp.726~731 (1989)
76. Petroni ML, "Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group", Eur J Gastroenterol Hepatol, 12, pp.695~700 (2000)
77. Rabenstein T, "Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones", Eur J Gastroenterol Hepatol, 17, pp.629~639 (2005)
78. Rosmorduc O, "Low phospholipid associated cholelithiasis:association with mutation in the MDR3", ABCB4 gene, 2007, pp.2, 29~
79. Marschall HU, "Gallstone disease", J Intern Med, 261, pp.529~542 (2007)

관련 논문AI추천